Herpes Zoster
12 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Amezosvatein Adjuvant Dose Arm D for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Adjuvant Dose Arm F for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Adjuvant Dose Arm H for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Adjuvant Dose Arm J for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Adjuvant Dose Arm L for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Antigen High Dose Arm A for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Amezosvatein Antigen Low Dose Arm B for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CVI-VZV-001 for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| dexmedetomidine nasal spray group + long duration high voltage pulse RF therapy group for herpes zoster | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-dose experimental vaccine for herpes zoster | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-dose experimental vaccine for herpes zoster | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant varicella zoster virus glycoprotein e antigen for herpes zoster | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |